Get it on Google Play

FDA accepts Kowa's glaucoma eye drop application, sets 2027 review date

August 27, 2026 11:03 AM EDT Send to a Friend
Kowa Pharmaceuticals America, Inc. announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login